Lodmell Donald L, Ewalt Larry C
Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, MT 59840, USA.
Vaccine. 2004 Sep 3;22(25-26):3237-9. doi: 10.1016/j.vaccine.2004.02.045.
Human exposure to rabid dogs in developing countries is an ongoing problem that continues to demand effective, safe, and affordable post-exposure rabies vaccinations. Sheep and suckling mouse brain rabies vaccines used in developing countries are being replaced by expensive inactivated-virus cell culture vaccines. Human studies using cell culture vaccines have determined that cost is reduced and protection is maintained by injecting the unused portion of vaccines that have been reconstituted and stored refrigerated for 1 week. Here we determined whether reconstituted purified chick embryo cell and human diploid cell vaccine that had been stored at 4 degrees C for intervals up to 1 year elicit neutralizing antibody, and protect mice against rabies virus. Undiluted, or 1:5 and 1:25 dilutions of both vaccines injected immediately after reconstitution, or after reconstitution and storage at 4 degrees C for 1 week, 1 month, 3 months, 6 months or 1 year elicited high levels of neutralizing antibody and protected 100% of the mice injected with rabies virus.
在发展中国家,人类接触狂犬病狗是一个持续存在的问题,仍然需要有效、安全且价格合理的暴露后狂犬病疫苗。发展中国家使用的绵羊和乳鼠脑狂犬病疫苗正被昂贵的灭活病毒细胞培养疫苗所取代。使用细胞培养疫苗的人体研究已经确定,通过注射已重新配制并冷藏保存1周的未使用部分疫苗,可以降低成本并保持保护效果。在这里,我们确定了在4摄氏度下储存长达1年的重新配制的纯化鸡胚细胞疫苗和人二倍体细胞疫苗是否能产生中和抗体,并保护小鼠免受狂犬病病毒感染。两种疫苗在重新配制后立即注射,或在重新配制并在4摄氏度下储存1周、1个月、3个月、6个月或1年后进行未稀释、1:5和1:25稀释注射,均能产生高水平的中和抗体,并保护100%注射狂犬病病毒的小鼠。